90 related articles for article (PubMed ID: 16556860)
1. PAI-1 and TGF-beta: unmasking the real driver of TGF-beta-induced vascular pathology.
Vaughan DE
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):679-80. PubMed ID: 16556860
[No Abstract] [Full Text] [Related]
2. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways.
Otsuka G; Agah R; Frutkin AD; Wight TN; Dichek DA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):737-43. PubMed ID: 16373605
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.
Otsuka G; Stempien-Otero A; Frutkin AD; Dichek DA
Circ Res; 2007 May; 100(9):1300-7. PubMed ID: 17431190
[TBL] [Abstract][Full Text] [Related]
4. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo.
Kairuz EM; Barber MN; Anderson CR; Kanagasundaram M; Drummond GR; Woods RL
Cardiovasc Res; 2005 Jun; 66(3):574-82. PubMed ID: 15914122
[TBL] [Abstract][Full Text] [Related]
5. Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells.
Scharpfenecker M; Kruse JJ; Sprong D; Russell NS; Ten Dijke P; Stewart FA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):506-13. PubMed ID: 19147015
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 and TGF-beta2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3.
Konrad L; Scheiber JA; Schwarz L; Schrader AJ; Hofmann R
Regul Pept; 2009 Jun; 155(1-3):28-32. PubMed ID: 19422858
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TGFbeta1-mediated PAI-1 induction by oltipraz through selective interruption of Smad 3 activation.
Cho IJ; Kim SH; Kim SG
Cytokine; 2006 Sep; 35(5-6):284-94. PubMed ID: 17095240
[TBL] [Abstract][Full Text] [Related]
9. The role of Smad3-dependent TGF-beta signal in vascular response to injury.
Yokote K; Kobayashi K; Saito Y
Trends Cardiovasc Med; 2006 Oct; 16(7):240-5. PubMed ID: 16980181
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.
Burke JP; Watson RW; Murphy M; Docherty NG; Coffey JC; O'Connell PR
Br J Surg; 2009 May; 96(5):541-51. PubMed ID: 19358180
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
13. Activity-dependent release of transforming growth factor-beta in a neuronal network in vitro.
Lacmann A; Hess D; Gohla G; Roussa E; Krieglstein K
Neuroscience; 2007 Dec; 150(3):647-57. PubMed ID: 17997227
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts.
Yamanaka O; Saika S; Ikeda K; Miyazaki K; Ohnishi Y; Ooshima A
Curr Eye Res; 2006 Jun; 31(6):491-9. PubMed ID: 16769608
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta signaling in vascular fibrosis.
Ruiz-Ortega M; Rodríguez-Vita J; Sanchez-Lopez E; Carvajal G; Egido J
Cardiovasc Res; 2007 May; 74(2):196-206. PubMed ID: 17376414
[TBL] [Abstract][Full Text] [Related]
17. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
19. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteome analysis of TGF-beta1-induced fibrosis processes in normal rat kidney interstitial fibroblast cells in response to ascofuranone.
Kang JH; Cho HJ; Lee IS; Kim M; Lee IK; Chang YC
Proteomics; 2009 Oct; 9(19):4445-56. PubMed ID: 19688726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
